Global Biologics Drug Development Market 2019 by Manufacturers, Countries, Type and Application, Forecast to 2024
出版日期：2019/07/29
頁 數：118頁
文件格式：PDF
價 格：
USD 3,480 (Single-User License)
USD 5,220 (Multi-User License)
USD 6,960 (Global-User License)
USD 5,220 (Multi-User License)
USD 6,960 (Global-User License)
Biologics are defined as pharmaceutical products obtained from living cells or microorganisms.
Scope of the Report:
The global Biologics Drug Development market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biologics Drug Development.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Biologics Drug Development market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologics Drug Development market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services
Market Segment by Applications, can be divided into
In-House
Outsource
Pharma Excess
Scope of the Report:
The global Biologics Drug Development market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biologics Drug Development.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Biologics Drug Development market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologics Drug Development market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Clinical Manufacturing
Formulation Development
Bioassay Development
Analytical Services
Market Segment by Applications, can be divided into
In-House
Outsource
Pharma Excess
Table of Contents
1 Biologics Drug Development Market Overview
1.1 Product Overview and Scope of Biologics Drug Development
1.2 Classification of Biologics Drug Development by Types
1.2.1 Global Biologics Drug Development Revenue Comparison by Types (2019-2024)
1.2.2 Global Biologics Drug Development Revenue Market Share by Types in 2018
1.2.3 Clinical Manufacturing
1.2.4 Formulation Development
1.2.5 Bioassay Development
1.2.6 Analytical Services
1.3 Global Biologics Drug Development Market by Application
1.3.1 Global Biologics Drug Development Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 In-House
1.3.3 Outsource
1.3.4 Pharma Excess
1.4 Global Biologics Drug Development Market by Regions
1.4.1 Global Biologics Drug Development Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Biologics Drug Development Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologics Drug Development Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologics Drug Development Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Biologics Drug Development Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologics Drug Development Status and Prospect (2014-2024)
1.5 Global Market Size of Biologics Drug Development (2014-2024)
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Business Overview
2.1.2 Biologics Drug Development Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Biologics Drug Development Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Biologics Drug Development Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.4 Charles River Laboratories
2.4.1 Business Overview
2.4.2 Biologics Drug Development Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.5 Catalent
2.5.1 Business Overview
2.5.2 Biologics Drug Development Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.6 Lonza Group
2.6.1 Business Overview
2.6.2 Biologics Drug Development Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.7 Amgen
2.7.1 Business Overview
2.7.2 Biologics Drug Development Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Biologics Drug Development Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biologics Drug Development Market Competition, by Players
3.1 Global Biologics Drug Development Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Biologics Drug Development Players Market Share
3.2.2 Top 10 Biologics Drug Development Players Market Share
3.3 Market Competition Trend
4 Global Biologics Drug Development Market Size by Regions
4.1 Global Biologics Drug Development Revenue and Market Share by Regions
4.2 North America Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.3 Europe Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.5 South America Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
5 North America Biologics Drug Development Revenue by Countries
5.1 North America Biologics Drug Development Revenue by Countries (2014-2019)
5.2 USA Biologics Drug Development Revenue and Growth Rate (2014-2019)
5.3 Canada Biologics Drug Development Revenue and Growth Rate (2014-2019)
5.4 Mexico Biologics Drug Development Revenue and Growth Rate (2014-2019)
6 Europe Biologics Drug Development Revenue by Countries
6.1 Europe Biologics Drug Development Revenue by Countries (2014-2019)
6.2 Germany Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.3 UK Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.4 France Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.5 Russia Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.6 Italy Biologics Drug Development Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Biologics Drug Development Revenue by Countries
7.1 Asia-Pacific Biologics Drug Development Revenue by Countries (2014-2019)
7.2 China Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.3 Japan Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.4 Korea Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.5 India Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Biologics Drug Development Revenue and Growth Rate (2014-2019)
8 South America Biologics Drug Development Revenue by Countries
8.1 South America Biologics Drug Development Revenue by Countries (2014-2019)
8.2 Brazil Biologics Drug Development Revenue and Growth Rate (2014-2019)
8.3 Argentina Biologics Drug Development Revenue and Growth Rate (2014-2019)
8.4 Colombia Biologics Drug Development Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Biologics Drug Development by Countries
9.1 Middle East and Africa Biologics Drug Development Revenue by Countries (2014-2019)
9.2 Saudi Arabia Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.3 UAE Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.4 Egypt Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.5 Nigeria Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.6 South Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
10 Global Biologics Drug Development Market Segment by Type
10.1 Global Biologics Drug Development Revenue and Market Share by Type (2014-2019)
10.2 Global Biologics Drug Development Market Forecast by Type (2019-2024)
10.3 Clinical Manufacturing Revenue Growth Rate (2014-2024)
10.4 Formulation Development Revenue Growth Rate (2014-2024)
10.5 Bioassay Development Revenue Growth Rate (2014-2024)
10.6 Analytical Services Revenue Growth Rate (2014-2024)
11 Global Biologics Drug Development Market Segment by Application
11.1 Global Biologics Drug Development Revenue Market Share by Application (2014-2019)
11.2 Biologics Drug Development Market Forecast by Application (2019-2024)
11.3 In-House Revenue Growth (2014-2019)
11.4 Outsource Revenue Growth (2014-2019)
11.5 Pharma Excess Revenue Growth (2014-2019)
12 Global Biologics Drug Development Market Size Forecast (2019-2024)
12.1 Global Biologics Drug Development Market Size Forecast (2019-2024)
12.2 Global Biologics Drug Development Market Forecast by Regions (2019-2024)
12.3 North America Biologics Drug Development Revenue Market Forecast (2019-2024)
12.4 Europe Biologics Drug Development Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Biologics Drug Development Revenue Market Forecast (2019-2024)
12.6 South America Biologics Drug Development Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Biologics Drug Development Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
1 Biologics Drug Development Market Overview
1.1 Product Overview and Scope of Biologics Drug Development
1.2 Classification of Biologics Drug Development by Types
1.2.1 Global Biologics Drug Development Revenue Comparison by Types (2019-2024)
1.2.2 Global Biologics Drug Development Revenue Market Share by Types in 2018
1.2.3 Clinical Manufacturing
1.2.4 Formulation Development
1.2.5 Bioassay Development
1.2.6 Analytical Services
1.3 Global Biologics Drug Development Market by Application
1.3.1 Global Biologics Drug Development Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 In-House
1.3.3 Outsource
1.3.4 Pharma Excess
1.4 Global Biologics Drug Development Market by Regions
1.4.1 Global Biologics Drug Development Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Biologics Drug Development Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologics Drug Development Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologics Drug Development Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Biologics Drug Development Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologics Drug Development Status and Prospect (2014-2024)
1.5 Global Market Size of Biologics Drug Development (2014-2024)
2 Manufacturers Profiles
2.1 Abbvie
2.1.1 Business Overview
2.1.2 Biologics Drug Development Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbvie Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Biologics Drug Development Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Biologics Drug Development Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.4 Charles River Laboratories
2.4.1 Business Overview
2.4.2 Biologics Drug Development Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Charles River Laboratories Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.5 Catalent
2.5.1 Business Overview
2.5.2 Biologics Drug Development Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Catalent Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.6 Lonza Group
2.6.1 Business Overview
2.6.2 Biologics Drug Development Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Lonza Group Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.7 Amgen
2.7.1 Business Overview
2.7.2 Biologics Drug Development Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Amgen Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
2.8 Sanofi
2.8.1 Business Overview
2.8.2 Biologics Drug Development Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi Biologics Drug Development Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biologics Drug Development Market Competition, by Players
3.1 Global Biologics Drug Development Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Biologics Drug Development Players Market Share
3.2.2 Top 10 Biologics Drug Development Players Market Share
3.3 Market Competition Trend
4 Global Biologics Drug Development Market Size by Regions
4.1 Global Biologics Drug Development Revenue and Market Share by Regions
4.2 North America Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.3 Europe Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.5 South America Biologics Drug Development Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
5 North America Biologics Drug Development Revenue by Countries
5.1 North America Biologics Drug Development Revenue by Countries (2014-2019)
5.2 USA Biologics Drug Development Revenue and Growth Rate (2014-2019)
5.3 Canada Biologics Drug Development Revenue and Growth Rate (2014-2019)
5.4 Mexico Biologics Drug Development Revenue and Growth Rate (2014-2019)
6 Europe Biologics Drug Development Revenue by Countries
6.1 Europe Biologics Drug Development Revenue by Countries (2014-2019)
6.2 Germany Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.3 UK Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.4 France Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.5 Russia Biologics Drug Development Revenue and Growth Rate (2014-2019)
6.6 Italy Biologics Drug Development Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Biologics Drug Development Revenue by Countries
7.1 Asia-Pacific Biologics Drug Development Revenue by Countries (2014-2019)
7.2 China Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.3 Japan Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.4 Korea Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.5 India Biologics Drug Development Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Biologics Drug Development Revenue and Growth Rate (2014-2019)
8 South America Biologics Drug Development Revenue by Countries
8.1 South America Biologics Drug Development Revenue by Countries (2014-2019)
8.2 Brazil Biologics Drug Development Revenue and Growth Rate (2014-2019)
8.3 Argentina Biologics Drug Development Revenue and Growth Rate (2014-2019)
8.4 Colombia Biologics Drug Development Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Biologics Drug Development by Countries
9.1 Middle East and Africa Biologics Drug Development Revenue by Countries (2014-2019)
9.2 Saudi Arabia Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.3 UAE Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.4 Egypt Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.5 Nigeria Biologics Drug Development Revenue and Growth Rate (2014-2019)
9.6 South Africa Biologics Drug Development Revenue and Growth Rate (2014-2019)
10 Global Biologics Drug Development Market Segment by Type
10.1 Global Biologics Drug Development Revenue and Market Share by Type (2014-2019)
10.2 Global Biologics Drug Development Market Forecast by Type (2019-2024)
10.3 Clinical Manufacturing Revenue Growth Rate (2014-2024)
10.4 Formulation Development Revenue Growth Rate (2014-2024)
10.5 Bioassay Development Revenue Growth Rate (2014-2024)
10.6 Analytical Services Revenue Growth Rate (2014-2024)
11 Global Biologics Drug Development Market Segment by Application
11.1 Global Biologics Drug Development Revenue Market Share by Application (2014-2019)
11.2 Biologics Drug Development Market Forecast by Application (2019-2024)
11.3 In-House Revenue Growth (2014-2019)
11.4 Outsource Revenue Growth (2014-2019)
11.5 Pharma Excess Revenue Growth (2014-2019)
12 Global Biologics Drug Development Market Size Forecast (2019-2024)
12.1 Global Biologics Drug Development Market Size Forecast (2019-2024)
12.2 Global Biologics Drug Development Market Forecast by Regions (2019-2024)
12.3 North America Biologics Drug Development Revenue Market Forecast (2019-2024)
12.4 Europe Biologics Drug Development Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Biologics Drug Development Revenue Market Forecast (2019-2024)
12.6 South America Biologics Drug Development Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Biologics Drug Development Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
